Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

Clinical trial NCT04967664 · COMPLETED

Trial details

NCT number: NCT04967664
Sponsor: Averitas Pharma, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Post Surgical Neuropathic Pain

Start date: 2021-07-13
Primary completion: 2025-08-28
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.